11-637294-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000797.4(DRD4):c.-11C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0517 in 1,196,094 control chromosomes in the GnomAD database, including 1,757 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.042 ( 157 hom., cov: 32)
Exomes 𝑓: 0.053 ( 1600 hom. )
Consequence
DRD4
NM_000797.4 5_prime_UTR
NM_000797.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0620
Genes affected
DRD4 (HGNC:3025): (dopamine receptor D4) This gene encodes the D4 subtype of the dopamine receptor. The D4 subtype is a G-protein coupled receptor which inhibits adenylyl cyclase. It is a target for drugs which treat schizophrenia and Parkinson disease. Mutations in this gene have been associated with various behavioral phenotypes, including autonomic nervous system dysfunction, attention deficit/hyperactivity disorder, and the personality trait of novelty seeking. This gene contains a polymorphic number (2-10 copies) of tandem 48 nt repeats; the sequence shown contains four repeats. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0659 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DRD4 | NM_000797.4 | c.-11C>T | 5_prime_UTR_variant | 1/4 | ENST00000176183.6 | NP_000788.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DRD4 | ENST00000176183.6 | c.-11C>T | 5_prime_UTR_variant | 1/4 | 1 | NM_000797.4 | ENSP00000176183 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0424 AC: 6396AN: 150986Hom.: 158 Cov.: 32
GnomAD3 genomes
AF:
AC:
6396
AN:
150986
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0515 AC: 319AN: 6198Hom.: 15 AF XY: 0.0503 AC XY: 201AN XY: 3994
GnomAD3 exomes
AF:
AC:
319
AN:
6198
Hom.:
AF XY:
AC XY:
201
AN XY:
3994
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0530 AC: 55428AN: 1045000Hom.: 1600 Cov.: 30 AF XY: 0.0533 AC XY: 26405AN XY: 495470
GnomAD4 exome
AF:
AC:
55428
AN:
1045000
Hom.:
Cov.:
30
AF XY:
AC XY:
26405
AN XY:
495470
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0424 AC: 6404AN: 151094Hom.: 157 Cov.: 32 AF XY: 0.0426 AC XY: 3146AN XY: 73860
GnomAD4 genome
AF:
AC:
6404
AN:
151094
Hom.:
Cov.:
32
AF XY:
AC XY:
3146
AN XY:
73860
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hereditary attention deficit-hyperactivity disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic | - | Potent mutations in Dopamine receptor uptake gene leads to decreased brain uptake of neuromodulator dopamine and are strongly associated with onset of Attention deficit hyperactivity disorder. However more evidence is required to confer the association of this particular rs146680769 with Attention deficit hyperactivity disorder. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at